FDA Commissioner Dr. Robert Califf to speak at Health Journalism ’22 in Austin

ByJeffrey J. Baker

Apr 8, 2022 #Andes Health Mart Store Number, #Ar Health Clinic, #Article About Oral Health, #Burden Of Health Disease Pdf, #Communication In Global Health Innovations, #Denver Metro Health Std Clinic, #Dept Of Health Provider Search, #Emory Health System Family, #Family Health Associates Dr Earl, #Family Health Center Labs, #Highmark Health Ratings, #Home Health Hiring Flyer, #Honor Health Cigna, #Horizon Health Brighton, #How Obesity Affects Community Health, #Hunion Health Chicago, #Indeed North American Mental Health, #Kings View Mental Health Affiliates, #Laramie Reproductive Health Rainbow Run, #Latino Perception Of Health, #Links Health And Human Services, #List Of Cheese Health, #Memorial Health Care Center Endocrinology, #Metro Health Foundation Facebook, #Nerium Eht Brain Health Supplement, #Nku Health Counseling And Prevention, #Nvq Level 2 Mental Health, #Odu Student Health Services Prices, #Poultry Health Mucous In Droppings, #Pre-Health Classes Uf, #Premium Value Health Savings Account, #Priya John Bombay Health Research, #Professor Public Opinion Health Care, #Programs That Offer Health Coaches, #Prominence Health Plan Leadership, #Prostitutes And Health, #Public Health Bloomfield Iowa, #Texas Health Family Care 410, #Together Health Lake Mary, #Tower Hill Uf Health Zaidi, #Traditional Dance Teachers Mental Health, #Trans Health Conference Philadelphia 2016, #Unskilled Home Health Care Denver, #Uo Masters Mental Health Counseling, #Upland Hills Health Foundation Board, #Urban Bee Hives Health, #Walker Whitman Public Health, #Wheeler'S Ranch Health Harmony Festival, #Women'S Health Choice Nottingham Way, #Www.Manet Community Health Center

[ad_1]

FDA Commissioner Robert Califf, M.D., M.A.C.C.

FDA Commissioner Robert Califf, M.D., M.A.C.C., will talk about the agency’s main priorities on Friday, April 29, at the Association of Health Care Journalists’ first conference since 2019. His remarks will be followed by a question-and-answer session.

Dr. Califf served as FDA commissioner at the end of the Obama administration. In returning to the post, he emphasized a need for the FDA to help counter misinformation about science that he says has become increasingly prevalent.

“These kinds of distortions and half-truths that find their way into the public domain do enormous harm, both by leading people to behavior that is detrimental to their health and by causing them to eschew interventions that would improve their health,” Califf said in a memo to staff.

Lessons from the pandemic, the health threat posed by e-cigarettes, pain management without addiction, and the pressures on the drug approval process will also likely be part of the conversation.

Califf was confirmed earlier this year as the 25th commissioner of the FDA — his second stint, having served in 2016.  Before assuming the role at that time, he was FDA’s Deputy Commissioner for Medical Products and Tobacco.

He has had a long career as a physician, researcher, and leader in science and medicine and is a nationally recognized expert in cardiovascular medicine, health outcomes research, health care quality and clinical research. He is also a leader in the growing field of translational research, which is key to ensuring that advances in science translate into medical care.

Prior to rejoining the FDA in 2022, Califf was head of medical strategy and senior advisor at Alphabet Inc., contributing to strategy and policy for its health subsidiaries Verily Life Sciences and Google Health. He joined Alphabet in 2019, after serving as a professor of medicine and vice chancellor for clinical and translational research at Duke University. He also served as director of the Duke Translational Medicine Institute and was the founding director of the Duke Clinical Research Institute.

Califf is a graduate of Duke University School of Medicine. He completed a residency in internal medicine at the University of California, San Francisco and a fellowship in cardiology at Duke.

[ad_2]

Source link